<DOC>
	<DOCNO>NCT02541084</DOCNO>
	<brief_summary>This study aim investigation caregiver burden Wet Age-related Macular Degeneration ( wAMD ) patient assessment much caregiver burden could reduce transition Pro Re Nata proactive therapy especially real-life rural setting public transportation readily available .</brief_summary>
	<brief_title>Caregiver Burden Wet Age-related Macular Degeneration ( wAMD ) Japan</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>[ Patients ] Female male outpatient diagnose wAMD . Patients accompany his/her caregiver ( ) . Patients receive antiVEGF therapy proactive regimen 12 month participate site . Providing informed consent participation study . [ Caregivers ] Providing inform consent participation study . Capable understand complete questionnaire without help others [ Patients ] Presence disease condition disable wAMD term caregiving . Presence intractable neurologic disease , physical handicap , mental handicap , condition render unable walk independently . Intraocular surgery eye diseases start wAMD therapy . [ Caregivers ] Professional carers</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Age-related macular degeneration</keyword>
	<keyword>Caregiver burden</keyword>
	<keyword>Anti-vascular endothelial growth factor ( VEGF ) therapy</keyword>
</DOC>